Hookipa Pharma News Today

Royal Bank of Canada reissued their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a report published on Tuesday morning, Benzinga reports. The firm currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their target price on shares of Hookipa Pharma from $6.50 to $5.00 and set […]

Royal Bank of Canada reaffirmed their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their price target on shares of Hookipa Pharma from […]

Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns.

Hookipa Pharma (NASDAQ:HOOK – Get Free Report) had its price target lowered by research analysts at HC Wainwright from $6.50 to $5.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Separately, Royal Bank of Canada restated an “outperform” rating and […]

Hookipa Pharma (NASDAQ:HOOK – Get Free Report) had its target price decreased by investment analysts at HC Wainwright from $6.50 to $5.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Separately, Royal Bank of Canada reaffirmed an “outperform” rating and […]

Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward.

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) – Research analysts at HC Wainwright boosted their Q1 2024 earnings per share (EPS) estimates for shares of Hookipa Pharma in a research report issued on Monday, March 25th. HC Wainwright analyst A. He now forecasts that the company will earn ($0.18) per share for the quarter, up […]

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) – Equities researchers at HC Wainwright issued their FY2028 earnings per share estimates for shares of Hookipa Pharma in a report released on Monday, March 25th. HC Wainwright analyst A. He forecasts that the company will post earnings of $0.31 per share for the year. HC Wainwright currently […]

Hookipa Pharma (NASDAQ:HOOK – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a research report issued on Monday, Benzinga reports. They currently have a $5.00 price target on the stock. Separately, HC Wainwright restated a “buy” rating and issued a $6.50 price objective on shares […]

Hookipa Pharma (NASDAQ:HOOK – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a note issued to investors on Monday, Benzinga reports. They currently have a $5.00 price objective on the stock. Separately, HC Wainwright reissued a “buy” rating and set a $6.50 price target on […]